Status:
UNKNOWN
Comparison of SBRTand Repeat TACE for HCC
Lead Sponsor:
Gangneung Asan Hospital
Collaborating Sponsors:
Soonchunhyang University Hospital
Conditions:
HepatoCellular Carcinoma
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Comparison of Stereotactic Body Radiation Therapy (SBRT) and repeated transarterial chemoembolization (TACE) for Hepatocellular Carcinoma (HCC)as a Local Salvage Treatment after first incomplete TACE
Detailed Description
The aim of this study is to evaluate the effect of SBRT after first incomplete TACE. In HCC patients with incomplete TACE response, repeated TACE did not showed good response. In this case, SBRT coul...
Eligibility Criteria
Inclusion
- Age \>18 years
- Eastern cooperative oncology group(ECOG) score 0 to 2
- Primary HCC
- HCC (single nodule ≤ 7 cm or max 3 nodules ≤ 3 cm)
- Child-Turgottei-Pugh A or B
- Unresectable lesion or medically contraindicated surgery or a case in which surgery was declined.
- No evidence of radiologically definable major vascular invasion or extrahepatic disease
- Previously incomplete TACE with radiologically defined residual disease after first TACE
- Informed consent
Exclusion
- Prior TACE to the target lesion
- Contraindication to receiving radiotherapy or TACE
- Decompensated liver cirrhosis
- Extrahepatic mets
- Pregnancy
- Patients with other cancers
Key Trial Info
Start Date :
March 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03326375
Start Date
March 1 2017
End Date
March 1 2021
Last Update
October 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gangneung Asan Hospital
Wŏnju, Gangwondo, South Korea, 25440